Rhonda Patrick· PhD
A pilot study found that patients with the highest blood levels of omega-3 fatty acids EPA and DHA were 75% less likely to die from COVID-19 compared to patients with low levels.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
A pilot study found that patients with the highest blood levels of omega-3 fatty acids EPA and DHA were 75% less likely to die from COVID-19 compared to patients with low levels.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
it was 0.07 p value so it wasn't statistically significant by standard metrics but in the race to understand what we can do about cobit we'll put up with a slightly non-significant strong trend in the right direction with good biology behind it to explain it
we looked at the people who had the highest quartile of omega-3 levels the 25 highest compared to everybody else who was lower and those people were really half as likely to die as people who had